NCT00829868View on ClinicalTrials.gov

Zaleplon 10 mg Capsules Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Healthy
Interventions
DRUG

Zaleplon 10 mg Capsules

1 x 10 mg

DRUG

SONATA® 10 mg capsules

1 x 10 mg

Trial Locations (1)

77042-4712

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00829868 - Zaleplon 10 mg Capsules Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter